Interference 105,004 Paper 18 DeBoer v. Gordon having successfully expressing a heterologous protein in the milk of a transgenic animal as of 1986. (JE005, Strijker declaration at 3, ¶7.) We conclude that the technical development of the field of the inventions was at an early stage in 1986. Consistently, Dr. Meade states that it was unknown whether a promoter from one species could effectively drive expression of a protein coding sequence from a second species in the mammary gland of a third species. (JE005 at 3–4, ¶9.) Dr. Strijker’s testimony is also consistent: as of 1986, “it had not been determined which, if any promoters, were suitable for the task, and what if any other regulatory sequences might be required to achieve expression in milk.” (JE007 at 3, ¶7.) We conclude from these statements that as of 1986, there was little empirical evidence relating to the efficacy of promoters taken from one species used in another. Thus, there was, as of the critical date, little if any basis for predicting the results of linking different regulatory sequences to other protein coding sequences. Particularly relevant to the status of the WAP promoter, Dr. Meade states that whey acid protein is specific to rodents, and is not normally present in the milk of ruminants. (JE007 at 3, ¶7.) Moreover, Dr. Meade states that there was no evidence that the WAP promoter would function in bovines (id.), and that, in 1986, he thought it would have been more likely that a milk promoter from a ruminant would facilitate expression of - 10 -Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 NextLast modified: November 3, 2007